ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,114 | -44.6% | 483,200 | -37.3% | 0.02% | -35.3% |
| Q2 2023 | $23,691 | -49.5% | 770,700 | -40.8% | 0.03% | -45.2% |
| Q1 2023 | $46,871 | +36.5% | 1,300,900 | +49.7% | 0.06% | +31.9% |
| Q4 2022 | $34,343 | -99.5% | 869,000 | +372.5% | 0.05% | +487.5% |
| Q1 2022 | $7,165,000 | -77.5% | 183,900 | -77.0% | 0.01% | -80.0% |
| Q4 2021 | $31,844,000 | +12.4% | 799,100 | +2.0% | 0.04% | +8.1% |
| Q3 2021 | $28,319,000 | -16.6% | 783,600 | -5.4% | 0.04% | -11.9% |
| Q2 2021 | $33,964,000 | – | 828,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |